Vimarsana
Biggest News Aggregation in the World

Page 32 - Sofinnova Partners News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sofinnova Partners. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sofinnova Partners Today - Breaking & Trending Today

MaxCyte Signs Strategic Platform License with Catamaran Bio to Support its CAR-NK Cell Therapy Programs - Vimarsana News

MaxCyte Signs Strategic Platform License with Catamaran Bio to Support its CAR-NK Cell Therapy Programs

MaxCyte's Flow Electroporation® and ExPERT technologies to be used to enhance Catamaran's TAILWIND® platform for novel CAR-NK cell therapies ROCKVILLE, Md, Jan. 3, 2023 /PRNewswire/

Swedish startup raises €21 million to accelerate the commercialisation of its cell-free biomanufacturing technology - Vimarsana News

Swedish startup raises €21 million to accelerate the commercialisation of its cell-free biomanufacturing technology

EnginZyme, a green tech company developing biomanufacturing processes for the sustainable manufacturing of everyday products, announced that it had raised €21 million in a Series B financing round ...

SITRYX THERAPEUTICS ANNOUNCES PARTICIPATION AT THE LONGWOOD HEALTHCARE LEADERS PRE-JPM WEBCONFERENCE, JANUARY 5TH & JANUARY 6TH, 2023 - Vimarsana News

SITRYX THERAPEUTICS ANNOUNCES PARTICIPATION AT THE LONGWOOD HEALTHCARE LEADERS PRE-JPM WEBCONFERENCE, JANUARY 5TH & JANUARY 6TH, 2023

/PRNewswire/ -- Sitryx Therapeutics Ltd (the "Company"), a biopharmaceutical company pioneering the field of immunometabolism, today announced that Neil Weir,...

SITRYX THERAPEUTICS ANNOUNCES PARTICIPATION AT THE LONGWOOD HEALTHCARE LEADERS PRE-JPM WEBCONFERENCE, JANUARY 5TH & JANUARY 6TH, 2023 - Vimarsana News

SITRYX THERAPEUTICS ANNOUNCES PARTICIPATION AT THE LONGWOOD HEALTHCARE LEADERS PRE-JPM WEBCONFERENCE, JANUARY 5TH & JANUARY 6TH, 2023

/PRNewswire/ -- Sitryx Therapeutics Ltd (the "Company"), a biopharmaceutical company pioneering the field of immunometabolism, today announced that Neil Weir,...

May Health Completes Treatment of Five Participants in U.S. Feasibility Study of its Ovarian Rebalancing Treatment for PCOS-related Infertility - Vimarsana News

May Health Completes Treatment of Five Participants in U.S. Feasibility Study of its Ovarian Rebalancing Treatment for PCOS-related Infertility

The targeted, one-time ovarian ablation procedure aims to induce ovulation for women seeking solutions for infertility related to the endocrine disorder polycystic ovary syndrome (PCOS)PARIS, FRANCE /